Refeeding and metabolic syndromes: Two sides of the same coin

Nutrition and Diabetes

Volumn 4, Issue JUNE, 2014, Pages

  Obeid, O A ^a   Hachem, D H ^a   Ayoub, J J ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; OIL; PHOSPHORUS; POTASSIUM; SWEETENING AGENT; SUGAR;

CARBOHYDRATE INTAKE; CEREAL; FOOD INTAKE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INSULIN RELEASE; LONG TERM EXPOSURE; MALNUTRITION; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFEEDING; REFEEDING SYNDROME; REVIEW; SODIUM RETENTION; DIETARY INTAKE; ELEVATED BLOOD PRESSURE; FOOD; HYPERLIPIDEMIA; HYPERMAGNESEMIA; INSULIN RESISTANCE; MAGNESIUM INTAKE; OBESITY; POSTPRANDIAL STATE; POTASSIUM INTAKE; PROCESSED FOOD; REHABILITATION; WESTERN DIET;

EID: 84903716057     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2014.21     Document Type: Review

References (86)

1. Boateng AA, Sriram K, Meguid MM, Crook M. Refeeding syndrome: Treatment considerations based on collective analysis of literature case reports. Nutrition 2010; 26: 156-167.
2. Fuentebella J, Kerner JA. Refeeding syndrome. Pediatr Clin N Am 2009; 56: 1201-1210.
3. National Heart Lung and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-3421.
4. Khan IR, Ahmed J, Khan S, MacFle J. Refeeding syndrome: A literature review. Gastroenterol Res and Pract 2011; 2011: doi:10.1155/2011/410971.
5. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J Clin Nutr 2012; 66: 201-208.
6. Khattab M, dit El-Khoury D, Azar S, Mattar M, Obeid O. Effect of phosphorus on the oral glucose tolerance test. Proc Nutr Soc 2011; 70: E60.
7. Popkin BM. Global nutrition dynamics: The world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 2006; 84: 289-298.
8. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes 2004; 28: S2-S9.
9. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver W. Uric acid, evolution, and primitive cultures. Sem Nephrol 2005; 25: 3-8.
10. Yusuf S, Reddy S, Ounouu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753.
11. Esmaillzadeh A, Kimiager M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 2007; 85: 910-918.
12. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: The atherosclerosis risk in communities study. Circulation 2008; 117: 754-761.
13. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract 2005; 1: 80-87.
14. Karczmar GS, Kurtz T, Tavares NJ, Weiner MW. Regulation of hepatic inorganic phosphate and ATP in response to fructose loading: An in vivo 31P-NMR study. Biochem Biophys Acta 1989; 1012: 121-127.
15. Lingelbach LB, McDonald RB. Description of the long-term lipogenic effects of dietary carbohydrates in male Fischer 344 rats. J Nutr 2004; 130: 3077-3084.
16. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Raeder D, Heiman M et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004; 89: 2963-2972.
17. Zammit VA, Waterman IJ, Topping D, McKay G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 2001; 131: 2074-2077.
18. Food and Agriculture Organization of the United Nations/FAOSTAT.PC. Food balanced sheets 2009. Accessed on 10 January 2014.
19. Drewnowski A. Obesity, diets, and social inequalities. Nutr Rev 2009; 67(Suppl 1): S36-S39.
20. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev 1997; 55: 31-43.
21. Popkin BM, Nielsen SJ. The sweetening of the world's diet. Obes Res 2003; 11: 1325-1332.
22. French S, Story M, Neumark-Sztainer D, Fulkerson JA, Hannan P. Fast food restaurant use among adolescents: Associations with nutrient intake, food choice, and behavioral and psychosocial variables. Int J Obes Relat Metab 2001; 25: 1823-1833.
23. Nielsen S, Siega-Riz A, Popkin BM. Trends in energy intake in the US between 1977 and 1996: similar shifts seen across age groups. Obes Res 2002; 10: 370-378.
24. Nielsen S, Siega-Riz A, Popkin BM. Trends in food locations and sources among adolescents and young adults. Prev Med 2002; 35: 107-113.
25. Haines P, Hama M, Guilkey DK, Popkin BM. Weekend eating in the United States is linked with greater energy, fat and alcohol intake. Obes Res 2003; 11: 945-949.
26. Jeffery R, Utter J. The changing environment and population obesity in the United States. Obes Res 2003; 11: 12S-22S.
27. Nielsen S, Popkin BM. Patterns and trends in portion sizes, 1977-1998. JAMA 2003; 289: 450-453.
28. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543.
29. Guthrie J, Lin B, Frazao E. Role of food prepared away from home in the American diet, 1977-78 versus 1994-96: changes and consequences. J Nutr Educ Behav 2002; 34: 140-150.
30. Paeratakul S, Ferdinand DP, Champagne CM, Ryan DH, Bray GA. Fast-food consumption among US adults and children: dietary and nutrient intake profile. J Am Diet Assoc 2003; 103: 1332-1338.
31. Håglin L. Hypophosphataemia: cause of the disturbed metabolism in the metabolic syndrome. Med Hypotheses 2001; 56: 657-663.
32. Lippi G, Montagnana M, Salvagno GL, Targher G, Guidi GC. Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients. Diabetes Res Clin Pract 2009; 84: e3-e5.
33. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A. Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 2006; 60: 734-739.
34. Friedman MI. Obesity and the hepatic control of feeding behavior. Drug News Perspect 2007; 20: 9.
35. Nair S, Chacko VP, Arnold C, Diehl M. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 2003; 98: 466-470.
36. Obeid OA, Dimachkie S, Hlais S. Increased phosphorus content of preload suppresses ad libitum energy intake at subsequent meal. Int J Obes 2010; 34: 1446-1448.
37. Nazar K, Kaciuba-Usciko H, Szczepanik J, Zemba AW, Kruk B, Chwalbiń ska-Moneta J et al. Phosphate supplementation prevents a decrease of triiodothyronine and increases resting metabolic rate during low energy diet. J Physiol Pharmacol 1996; 47: 373-383.
38. Jaedig S, Lindgärde F, Arborelius M. Increased postprandial energy expenditure in obese women after peroral K- And Mg-phosphate. Miner Electrolyte Metab 1994; 20: 147-152.
39. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 2007; 20: 107-129.
40. Obeid O. Low phosphorus status might contribute to the onset of obesity. Obes Rev 2013; 14: 659-664.
41. Celik N, Andiran N. The relationship between serum phosphate levels with childhood obesity and insulin resistance. J Pediatr Endocrinol Metab 2011; 24: 81-83.
42. Holecki M, Chudek J, Wiecek A, Titz-Bober M, Dulawa J. The serum level of fibroblast growth factor-23 and calcium-phosphate homeostasis in obese perimenopausal women. Int J Endocrinol 2011; 2011: 707126.
43. Alonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A et al. Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension 2010; 55: 776-784.
44. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404.
45. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC et al. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: A double-edged sword. Diabetes Res Clin Pract 2009; 83: 119-125.
46. Dhingra R, Sullivan LM, Fox SC, Wang TJ, D'Agostino RB, Gaziano JM et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-885.
47. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: Another feature of metabolic syndrome. Am J Kidney Dis 2005; 45: 851-858.
48. Haglin L, Lindbland A, Bygren LO. Hypophosphatemia in the metabolic syndrome. Gender differences in body weight and blood glucose. Eur J Clin Nutr 2001; 55: 493-498.
49. Ljunghall S, Hvarfner A, Lind L. Clinical studies of calcium metabolism in essential hypertension. Eur Heart J 1987; 8(Suppl B): 37-44.
50. Farhangi MA, Ostadrahimi A, Mahdoob S. Serum calcium, magnesium, phosphorus and lipid profile in healthy Iranian premenopausal women. Biochemia Medica 2011; 21: 312-320.
51. Gudmundsdottir H, Starnd AH, Kjeldsen SE, Hoieggen A, Os I. Serum phosphate, blood pressure, and the metabolic syndrome-20-year follow up of middle-aged men. J Clin Hypertens (Greenwich) 2008; 10: 814-821.
52. Vyssoulis G, Karpanou E, Tzamou V, Kyvelou SM, Michaelidis A, Stefanadis C. Serum phosphate in white-coat hypertensive patients: focus on dipping status and metabolic syndrome. Hypertens Res 2010; 33: 825-830.
53. Elliott P, Kesteloot H, Appel LJ, Duer AR, Ueshima H, Chan Q. Dietary phosphorus and blood pressure: Intesnational study of macro- And micro-nutrients and blood pressure. Hypertension 2008; 51: 669-675.
54. Hajjar I, Kotchen T. Regional variations of blood pressure in the united states are associated with regional variations in dietary intake: The NHANES-III Data. J Nutr 2003; 133: 211-214.
55. Kesteloot H, Joossens JV. Relationship of serum sodium, potassium calcium, and phosphorus with blood pressure. Belgian Interunivesrity Research on Nutrition and Health Hypertension 1988; 12: 589-593.
56. Kjeldesen SE, Os I, Westheim A, Frederichsen P, Hjermann I, Eide IK. Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone. Am J Hypertens 1988; 1: 403-409.
57. Harlan WR, Hull AL, Schmouder RL, Landis JR, Thompson FE, Larkin FA. Blood pressure and nutrition in adults. The National Health and Nutrition Examination Survey. Am J Epidemiol 1984; 120: 17-28.
58. Daniels J, Goodman DA. Hypertension and Hyperparathyroidism. Inverse relation of serum phosphate level and blood pressure. Am J Med 1983; 75: 17-23.
59. Havlik RJ, Garrison RJ, Feinleib M, Padgett S, Castelli WP, McNamara PM. Evidence for additional blood pressure correlates in adults 20-56 years old. Circulation 1980; 61: 710-715.
60. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: A meta-analysis. Eur J Clin Nutr 2012; 66: 411-418.
61. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health-Syst Pharm 2004; 61: 1569-1576.
62. Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. Am Fam Physician 2009; 80: 157-162.
63. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006; 113: 1675-1682.
64. Song Y, Ridker PM, Manson JE, Cook NR, Burning JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care. 2005; 28: 1438-1444.
65. Ford ES, Li C, McGuire LC, Mokdad AH, Liu S. Intake of dietary magnesium and the prevalence of the metabolic syndrome among US adults. Obesity 2007; 15: 1139-1146.
66. Lima ML, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome- Evidence for its relation to insulin resistance. Diabetes Res Clin Pract 2009; 83: 257-262.
67. Corica F, Corsonello A, Ientile R, Cucinotta D, Di Bendetto A, Perticone F. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 2006; 25: 210-215.
68. Yajnik CS, Smith RF, Hockaday TDR, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J 1984; 288: 1032-1035.
69. Zofkova I, Nedvidkove J, Zamrazil V, Simeckova A. Influence of magnesium on glucose tolerance acute hypomagnesemia reduces the glucose tolerance independently on hormonal indicators. Horm Metabol Res 1987; 19: 228-229.
70. Kishimoto Y, Tani M, Uto-Kondo H, Saita E, Iizuka M, Sone H. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 2010; 103: 469-472.
71. Witteman JC, Grobee DE, Derkx FH, Bouillon R, de Bruijn AM, Hofman A. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. J Clin Nutr 1994; 60: 129-135.
72. He FJ, MacGregor GA. Beneficial effects of potassium on human health. Physiol Plant 2008; 133: 725-735.
73. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficienc on glucose and insulin metabolism. Metabolism 1980; 29: 498-505.
74. Dluhy RG, Axelrod L, Williams GH. Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man. J Appl Physiol 1972; 33: 22-27.
75. Resnick LM, Barbagallo M, Dominguez LJ, Veniero JM, Nicholson JP, Gupta RK. Relation of cellular potassium to other mineral ions in hypertension and diabetes. Hypertension 2001; 38: 709-712.
76. Teramoto T, Kawamori R, Miyazaki S, Teramukai S. Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA Study. Hypertens Res 2011; 34: 957-962.
77. Fujita T, Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int 1983; 24: 731-739.
78. Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 1984; 6: 184-192.
79. Ogihara T, Asano T, Ando K et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl saltsensitive rats. Hypertension 2002; 40: 83-89.
80. Fujita T. Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol Dial Transplant 2007; 22: 3102-3107.
81. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005; 28: 2823-2831.
82. Lee H, Lee J, Hwang S, Kim S, Chin HJ, Han JS. Potassium intake and the prevalence of metabolic syndrome: The Korea National Health and Nutrition Examintaion Survey 2008-2010. PLoS One 2013; 8: 1-9.
83. Yanovski JA, Parikh SJ, Yanoff LB, Denkinger BI, Calis KA, Reynolds JC. Effects of calcium supplementation on body weight and adiposity in overweight and obese adults: A randomized trial. Ann Intern Med 2009; 150: W145-W146.
84. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012; 142: 1304-1313.
85. Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D. Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 2002; 25: 1522-1528.
86. Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998; 30: 281-284.